José P.
- Country
- Spain
- Department
- Intern Medicine
Research Overview
- Phase III Randomized Double‑Blind Trial of Elecoglipron (AZD5004) on Cardiovascular Mortality and Hospitalization in Adults with HFpEF or HFmrEF on Background Dapagliflozin
- Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of Ponsegromab in Adults with Heart Failure
- Evaluation of Intra-Abdominal Pressure and Ultrasound-Guided Diuretic Therapy with Furosemide and Hydrochlorothiazide in Acute Heart Failure Patients
Data & Insights
Has run more than one trial at 34 of 284 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in the field of heart failure management and conducts research on innovative therapeutic approaches for both acute and chronic conditions.
- Chronic Heart Failure Treatment
- Acute Heart Failure Interventions
- Quality of Life Assessment
Their work encompasses evaluating novel therapeutic agents and their impact on patient outcomes in heart failure.
Diagnostic Innovation
Expertise in implementing advanced diagnostic techniques, particularly focusing on point-of-care ultrasound and monitoring approaches in cardiac care.
- Ultrasound-Guided Therapy
- Intra-abdominal Pressure Monitoring
- Congestion Assessment
The investigator explores integrated diagnostic approaches to guide therapeutic decisions in heart failure management.
Treatment Optimization
Focus on decongestive therapy optimization and development of targeted treatment strategies for heart failure patients.
- Diuretic Treatment Protocols
- Novel Therapeutic Agents
- Treatment Response Assessment
Their research aims to enhance treatment effectiveness through precise therapeutic interventions and monitoring strategies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.